# Tapinarof (Vtama)

Source: https://ourhealthnetwork.com/drugs/tapinarof
Data: FDA Orange Book and OpenFDA, refreshed periodically

## What is Tapinarof?

Tapinarof (brand name: Vtama) is an aryl hydrocarbon receptor agonist taken topical. It is prescribed to treat psoriasis. Across the United States, 159 doctors prescribe Tapinarof to approximately 570 Medicare patients.

## Brand names

Vtama

## Indications

Tapinarof is primarily prescribed for the treatment of psoriasis.

## Conditions treated

- [Psoriasis](https://ourhealthnetwork.com/conditions/psoriasis)

## Mechanism of action

Tapinarof is an aryl hydrocarbon receptor (AhR) agonist. The specific mechanisms by which VTAMA cream exerts its therapeutic actions are unknown.

## Drug classification

- Established Pharmacologic Class: Aryl Hydrocarbon Receptor Agonist [EPC]
- Mechanism of Action class: Aryl Hydrocarbon Receptor Agonists [MoA]
- Route of administration: TOPICAL

## Common side effects

a cream were contact dermatitis, and folliculitis, and male, contact dermatitis, folliculitis, headache, influenza, nasopharyngitis

## Sources and disclaimers

- FDA Orange Book and OpenFDA dataset
- This information is for educational purposes only and does not constitute medical advice. Always consult a healthcare professional before starting, stopping, or changing any medication.

## Related

- [All drugs](https://ourhealthnetwork.com/drugs)
- [Find specialists who prescribe this drug](https://ourhealthnetwork.com/find-doctors)
- [Methodology](https://ourhealthnetwork.com/methodology)